Mersana Therapeutics(MRSN) - 2025 Q1 - Earnings Call Transcript

Mersana Therapeutics (MRSN) Q1 2025 Earnings Call May 15, 2025 08:00 AM ET Company Participants Jason Fredette - Senior Vice President of Investor Relations & Corporate CommunicationsMartin Huber - President & CEOBrian DeSchuytner - Senior VP, CFO & COOJonathan Chang - Senior Managing DirectorKarina Rabayeva - VP - Biotech Equity Research Conference Call Participants Tara Bancroft - Director, Senior Analyst, Biotech Equity ResearchCharles Zhu - Managing Director, Senior Biotechnology Research AnalystMichael ...